Metabolic Coordination of Physiological and Pathological Cardiac Remodeling

被引:274
|
作者
Gibb, Andrew A. [1 ]
Hill, Bradford G. [2 ]
机构
[1] Temple Univ, Ctr Translat Med, Lewis Katz Sch Med, Philadelphia, PA 19122 USA
[2] Univ Louisville, Dept Med, Inst Mol Cardiol, Diabet & Obes Ctr,Sch Med, Louisville, KY 40292 USA
基金
美国国家卫生研究院;
关键词
exercise; glucose; heart failure; hypertrophy; mitochondria; pregnancy; systems biology; FATTY-ACID OXIDATION; PENTOSE-PHOSPHATE PATHWAY; ACTIVATED PROTEIN-KINASE; WORKING RAT-HEART; IDIOPATHIC DILATED CARDIOMYOPATHY; LEFT-VENTRICULAR HYPERTROPHY; CHAIN AMINO-ACIDS; PRESSURE-OVERLOAD HYPERTROPHY; ISCHEMIA-REPERFUSION INJURY; OBESE ZUCKER RATS;
D O I
10.1161/CIRCRESAHA.118.312017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metabolic pathways integrate to support tissue homeostasis and to prompt changes in cell phenotype. In particular, the heart consumes relatively large amounts of substrate not only to regenerate ATP for contraction but also to sustain biosynthetic reactions for replacement of cellular building blocks. Metabolic pathways also control intracellular redox state, and metabolic intermediates and end products provide signals that prompt changes in enzymatic activity and gene expression. Mounting evidence suggests that the changes in cardiac metabolism that occur during development, exercise, and pregnancy as well as with pathological stress (eg, myocardial infarction, pressure overload) are causative in cardiac remodeling. Metabolism-mediated changes in gene expression, metabolite signaling, and the channeling of glucose-derived carbon toward anabolic pathways seem critical for physiological growth of the heart, and metabolic inefficiency and loss of coordinated anabolic activity are emerging as proximal causes of pathological remodeling. This review integrates knowledge of different forms of cardiac remodeling to develop general models of how relationships between catabolic and anabolic glucose metabolism may fortify cardiac health or promote (mal)adaptive myocardial remodeling. Adoption of conceptual frameworks based in relational biology may enable further understanding of how metabolism regulates cardiac structure and function.
引用
收藏
页码:107 / 128
页数:22
相关论文
共 50 条
  • [21] Cardiac Stim1 Silencing Prevents Physiological Cardiac Hypertrophy and Promotes Pathological Remodeling in Exercised Mice
    Bonilla, Ingrid M.
    Baine, Stephen
    Belevych, Andriy
    Gyorke, Sandor
    CIRCULATION, 2019, 140
  • [22] Cardiac Remodeling During Pregnancy With Challenge: A Prologue of Pathological Remodeling
    Yang, Yijun
    Kurian, Justin
    Schena, Giana
    Johnson, Jaslyn
    Kubo, Hajime
    Kang, Chunya
    Lucchese, Anna Maria
    Eaton, Deborah
    Khan, Mohsin
    Mohsin, Sadia
    Houser, Steven R.
    CIRCULATION, 2020, 142
  • [23] Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking
    Goldenberg, Joseph R.
    Carley, Andrew N.
    Ji, Ruiping
    Zhang, Xiaokan
    Fasano, Matt
    Schulze, P. Christian
    Lewandowski, E. Douglas
    CIRCULATION, 2019, 139 (24) : 2765 - 2777
  • [24] Mechanisms of physiological and pathological cardiac hypertrophy
    Nakamura, Michinari
    Sadoshima, Junichi
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (07) : 387 - 407
  • [25] Mechanisms of physiological and pathological cardiac hypertrophy
    Michinari Nakamura
    Junichi Sadoshima
    Nature Reviews Cardiology, 2018, 15 : 387 - 407
  • [26] Repurposing Nintedanib for pathological cardiac remodeling and dysfunction
    Umbarkar, Prachi
    Singh, Anand P.
    Tousif, Sultan
    Zhang, Qinkun
    Sethu, Palaniappan
    Lal, Hind
    PHARMACOLOGICAL RESEARCH, 2021, 169
  • [27] Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin
    Burke, Ryan M.
    Dirkx, Ronald A., Jr.
    Quijada, Pearl
    Lighthouse, Janet K.
    Mohan, Amy
    O'Brien, Meghann
    Wojciechowski, Wojciech
    Woeller, Collynn F.
    Phipps, Richard P.
    Alexis, Jeffrey D.
    Ashton, John M.
    Small, Eric M.
    CIRCULATION RESEARCH, 2021, 128 (11) : 1663 - 1678
  • [28] TFAM overexpression reduces pathological cardiac remodeling
    George H. Kunkel
    Christopher J. Kunkel
    Hazel Ozuna
    Irina Miralda
    Suresh C. Tyagi
    Molecular and Cellular Biochemistry, 2019, 454 : 139 - 152
  • [29] Pathological cardiac remodeling seen by the eyes of proteomics
    Gomez-Mendoza, Diana Paola
    Lara-Ribeiro, Ana Carolina
    Verano-Braga, Thiago
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2021, 1869 (06):
  • [30] Role of resveratrol in inhibiting pathological cardiac remodeling
    Fan, Shaowei
    Hu, Yuanhui
    You, Yaping
    Xue, Wenjing
    Chai, Ruoning
    Zhang, Xuesong
    Shou, Xintian
    Shi, Jingjing
    FRONTIERS IN PHARMACOLOGY, 2022, 13